$BSX Income Statement | Understand Stock

$BSX

$45.58 -$0.11 (0.24%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Net sales
Cost of products sold (excluding amortization expense)
Gross profit
Operating expenses:
Selling, general and administrative expenses
Research and development expenses
Royalty expense
Amortization expense
Goodwill impairment charges
Intangible asset impairment charges
Contingent consideration net expense (benefit)
Restructuring net charges (credits)
Litigation-related net charges (credits)
Loss (Gain) on Disposal of Businesses and Assets
Operating expenses

Operating income (loss)
Other income (expense):
Interest expense
Other, net
Income (loss) before income taxes
Income tax expense (benefit)
Net income (loss)
Preferred stock dividends
Net income (loss) attributable to noncontrolling interests
Net income (loss) attributable to Boston Scientific common stockholders
Net income (loss) per common share — basic
Net income (loss) per common share — diluted
Weighted-average shares outstanding
Basic
Diluted

Comments